Globus Medical, founded in 2003, is a rapidly growing company focused on solving musculoskeletal problems. The company operates globally, with its primary market in the United States. The projected revenue for the group in 2024 is $2.5 billion. Globus stands out from other industry players through substantial investments in in-house product development and manufacturing. Synoste’s 13-member team became part of Globus through an acquisition in 2020, adding wireless technology for extending tibia and femur bones to the portfolio. Now, the story continues as new projects begin.
